Compare PROF & MBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROF | MBI |
|---|---|---|
| Founded | N/A | 1973 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.8M | 227.5M |
| IPO Year | 2017 | 1994 |
| Metric | PROF | MBI |
|---|---|---|
| Price | $7.44 | $4.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $11.14 | $6.00 |
| AVG Volume (30 Days) | 184.5K | ★ 299.5K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.89 | ★ 62.04 |
| EPS | ★ N/A | N/A |
| Revenue | $16,098,000.00 | ★ $80,000,000.00 |
| Revenue This Year | $61.76 | N/A |
| Revenue Next Year | $70.98 | $19.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 50.73 | ★ 90.48 |
| 52 Week Low | $4.91 | $4.19 |
| 52 Week High | $8.95 | $7.85 |
| Indicator | PROF | MBI |
|---|---|---|
| Relative Strength Index (RSI) | 62.40 | 55.37 |
| Support Level | $6.38 | $4.26 |
| Resistance Level | $7.92 | $6.26 |
| Average True Range (ATR) | 0.50 | 0.20 |
| MACD | 0.13 | 0.03 |
| Stochastic Oscillator | 75.61 | 67.27 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. The U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiaries.